It is a healthcare public limited company based in Patan, Gujarat, India, established in 2020.
2020 | Patan, Gujarat, India | ActiveSabarimala Hospital And Research Center Limited, a active public limited company, was established on 25 August 2020 in Patan, Gujarat, India. Engaging in hospitals within the hospital and medical care sector, it holds CIN: U85100GJ2020PLC115813. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Moni Mukeshkumar Patel (Director), Jolly Maheshkumar Patel (Director), Parth Mukeshkumar Patel (Managing Director). Past directors included Sangita Dharmendrakumar Shah, Sanket Vinodkumar Patel, Parth Mukeshkumar Patel. It holds ₹5.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-1, Second Floor, Sardar Complex, Vill Patan, Tal Patan,, Patan, Gujarat, 384265.
U85100GJ2020PLC115813
115813
25 August 2020
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Sabarimala Hospital And Research Center Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Moni Mukeshkumar Patel | Director | 22 Jan 2021 | Current |
| Jolly Maheshkumar Patel | Director | 14 Oct 2021 | Current |
| Parth Mukeshkumar Patel | Managing Director | 25 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jan 2021 | Past |
| Pramod Abcsdd | Director | 26 Dec 2022 | Past |
| Pramod Abcsdd | Director | 28 May 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sabarimala Hospital And Research Center Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.33% increase. The company also saw a substantial improvement in profitability, with a 35.82% increase in profit. The company's net worth Soared by an impressive increase of 49.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sabarimala Hospital And Research Center had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹52,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Oct 2025 | Others | ₹5.25 Cr | Open |
Explore comprehensive loan charge details -
Sabarimala Hospital And Research Center has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sabarimala Hospital And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sabarimala Hospital And Research Center's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 52.50 M with Charge ID 101185776 was registered on 06 Oct 2025. was recorded as a recent event.
The activity Sabarimala Hospital And Research Center Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Sabarimala Hospital And Research Center Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Jolly Maheshkumar Patel was appointed as a Director was appointed as a Director on 14 Oct 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
Moni Mukeshkumar Patel was appointed as a Director was appointed as a Director on 22 Jan 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
Parth Mukeshkumar Patel was appointed as a Managing Director was appointed as a Managing Director on 25 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
The CIN of Sabarimala Hospital And Research Center Limited is U85100GJ2020PLC115813.
Sabarimala Hospital And Research Center Limited is headquartered at B-1, Second Floor, Sardar Complex, Vill Patan, Tal Patan,, Patan, Gujarat, 384265.
Sabarimala Hospital And Research Center Limited was incorporated on 25 August 2020.
The current directors of Sabarimala Hospital And Research Center Limited are
The primary industry of Sabarimala Hospital And Research Center Limited is Hospital And Medical Care.
Sabarimala Hospital And Research Center Limited is unlisted.
The authorized capital of Sabarimala Hospital And Research Center Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX